LA
GSK icon

LM Advisors’s GSK GSK Stock Holding History

LM Advisors’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-225
Closed -$4.56K – 218
2025
Q4 		$4.56K Sell
225
-5,294
-96% -$247K 0.08% 130
2025
Q3 		$240K Sell
5,519
-196
-3% -$7.66K 0.03% 188
2025
Q2 		$219K Hold
5,715
– – 0.03% 178
2025
Q1 		$221K Buy
+5,715
New +$209K 0.04% 204
2024
Q4 		– Sell
-5,857
Closed -$239K – 193
2024
Q3 		$239K Sell
5,857
-220
-4% -$9K 0.05% 157
2024
Q2 		$234K Sell
6,077
-5,584
-48% -$235K ﹤0.01% 172
2024
Q1 		$404K Buy
11,661
+1,300
+13% +$53.6K 0.06% 152
2023
Q4 		$384K Buy
+10,361
New +$372K 0.08% 138

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

LM Advisors's GSK Position: Q1 2026 in Review

LM Advisors sold out of GSK (GSK) in Q1 2026, closing a stake of 225 shares — an estimated $4.56K sold.

LM Advisors first reported a position in GSK in Q4 2023 and held it in 8 quarters. The position peaked at $404K in Q1 2024. 1,035 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

  • LM Advisors reported no remaining GSK position as of Q1 2026 after selling out during the quarter.
  • LM Advisors sold 225 GSK shares in Q1 2026, an estimated $4.56K.
  • LM Advisors first reported a position in GSK in Q4 2023 and held it in 8 quarters.
  • LM Advisors's GSK position peaked at $404K in Q1 2024.
  • 1,035 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on LM Advisors's 13F filing for Q1 2026, filed 14 May 2026.